Synergic effect of oral contraceptives, gstp1 polymorphisms, and high-risk hpv infection in development of cervical lesions

B. S. Chagas, A. P.A.D. Gurgel, S. S.L. Paiva Júnior, R. C.P. Lima, M. N. Cordeiro, R. R. Moura, R. R. Moura, A. V.C. Coelho, K. C.G. Nascimento, J. C. Silva Neto, S. Crovella, S. Crovella, S. Crovella, A. C. Freitas

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

© 2017 The Authors. Human papillomavirus (HPV) infection is considered a risk factor for cervical cancer. Even if the high-risk HPV (HR-HPV) infection is necessary, environmental co-factors and genetic susceptibility also play an important role in cervical cancer development. In this study, a possible association of rs1695 GSTP1 polymorphisms, HR-HPV infection, and oral contraceptive use with cancer lesion development in women was investigated. The study population comprised 441 Brazilian women from the Northeast region including 98 HPV-infec ted women with high-grade squamous intraepithelial lesions, 77 HPV-infected women with low-grade squamous intraepithelial lesions, and 266 HPV-negative women with no lesion, used as a control. Our data did not show a significant association between the GSTP1 polymorphism A/G (rs1695) and any HPV-related cervical abnormalities. However, considering the use of oral contraceptives, the GSTP1 rs1695 polymorphism was associated with higher susceptibility to the development of cervical lesions in HR-HPV-infected women. Our study suggests a synergic effect of oral contraceptive use, GSTP1 polymorphisms, and HR-HPV infection in the development of cervical lesions. Together, these risk factors may induce neoplastic transformation of the cervical squamous epithelium, setting conditions for secondary genetic events leading to cervical cancer.
Original languageEnglish
JournalGenetics and Molecular Research
Volume16
Issue number3
DOIs
Publication statusPublished - Aug 17 2017

Fingerprint

Oral Contraceptives
Infection
Uterine Cervical Neoplasms
Papillomavirus Infections
Genetic Predisposition to Disease
Epithelium
Population
Neoplasms

Keywords

  • Cervical cancer
  • Contraceptive
  • Glutathione S-transferase
  • Human papillomavirus

Cite this

Chagas, B. S., Gurgel, A. P. A. D., Paiva Júnior, S. S. L., Lima, R. C. P., Cordeiro, M. N., Moura, R. R., ... Freitas, A. C. (2017). Synergic effect of oral contraceptives, gstp1 polymorphisms, and high-risk hpv infection in development of cervical lesions. Genetics and Molecular Research, 16(3). https://doi.org/10.4238/gmr16039742

Synergic effect of oral contraceptives, gstp1 polymorphisms, and high-risk hpv infection in development of cervical lesions. / Chagas, B. S.; Gurgel, A. P.A.D.; Paiva Júnior, S. S.L.; Lima, R. C.P.; Cordeiro, M. N.; Moura, R. R.; Moura, R. R.; Coelho, A. V.C.; Nascimento, K. C.G.; Silva Neto, J. C.; Crovella, S.; Crovella, S.; Crovella, S.; Freitas, A. C.

In: Genetics and Molecular Research, Vol. 16, No. 3, 17.08.2017.

Research output: Contribution to journalArticle

Chagas, BS, Gurgel, APAD, Paiva Júnior, SSL, Lima, RCP, Cordeiro, MN, Moura, RR, Moura, RR, Coelho, AVC, Nascimento, KCG, Silva Neto, JC, Crovella, S, Crovella, S, Crovella, S & Freitas, AC 2017, 'Synergic effect of oral contraceptives, gstp1 polymorphisms, and high-risk hpv infection in development of cervical lesions', Genetics and Molecular Research, vol. 16, no. 3. https://doi.org/10.4238/gmr16039742
Chagas, B. S. ; Gurgel, A. P.A.D. ; Paiva Júnior, S. S.L. ; Lima, R. C.P. ; Cordeiro, M. N. ; Moura, R. R. ; Moura, R. R. ; Coelho, A. V.C. ; Nascimento, K. C.G. ; Silva Neto, J. C. ; Crovella, S. ; Crovella, S. ; Crovella, S. ; Freitas, A. C. / Synergic effect of oral contraceptives, gstp1 polymorphisms, and high-risk hpv infection in development of cervical lesions. In: Genetics and Molecular Research. 2017 ; Vol. 16, No. 3.
@article{d7b4581aa1b340f7b004a07a3cf3e48b,
title = "Synergic effect of oral contraceptives, gstp1 polymorphisms, and high-risk hpv infection in development of cervical lesions",
abstract = "{\circledC} 2017 The Authors. Human papillomavirus (HPV) infection is considered a risk factor for cervical cancer. Even if the high-risk HPV (HR-HPV) infection is necessary, environmental co-factors and genetic susceptibility also play an important role in cervical cancer development. In this study, a possible association of rs1695 GSTP1 polymorphisms, HR-HPV infection, and oral contraceptive use with cancer lesion development in women was investigated. The study population comprised 441 Brazilian women from the Northeast region including 98 HPV-infec ted women with high-grade squamous intraepithelial lesions, 77 HPV-infected women with low-grade squamous intraepithelial lesions, and 266 HPV-negative women with no lesion, used as a control. Our data did not show a significant association between the GSTP1 polymorphism A/G (rs1695) and any HPV-related cervical abnormalities. However, considering the use of oral contraceptives, the GSTP1 rs1695 polymorphism was associated with higher susceptibility to the development of cervical lesions in HR-HPV-infected women. Our study suggests a synergic effect of oral contraceptive use, GSTP1 polymorphisms, and HR-HPV infection in the development of cervical lesions. Together, these risk factors may induce neoplastic transformation of the cervical squamous epithelium, setting conditions for secondary genetic events leading to cervical cancer.",
keywords = "Cervical cancer, Contraceptive, Glutathione S-transferase, Human papillomavirus",
author = "Chagas, {B. S.} and Gurgel, {A. P.A.D.} and {Paiva J{\'u}nior}, {S. S.L.} and Lima, {R. C.P.} and Cordeiro, {M. N.} and Moura, {R. R.} and Moura, {R. R.} and Coelho, {A. V.C.} and Nascimento, {K. C.G.} and {Silva Neto}, {J. C.} and S. Crovella and S. Crovella and S. Crovella and Freitas, {A. C.}",
year = "2017",
month = "8",
day = "17",
doi = "10.4238/gmr16039742",
language = "English",
volume = "16",
journal = "Genetics and Molecular Research",
issn = "1676-5680",
publisher = "Fundacao de Pesquisas Cientificas de Ribeirao Preto",
number = "3",

}

TY - JOUR

T1 - Synergic effect of oral contraceptives, gstp1 polymorphisms, and high-risk hpv infection in development of cervical lesions

AU - Chagas, B. S.

AU - Gurgel, A. P.A.D.

AU - Paiva Júnior, S. S.L.

AU - Lima, R. C.P.

AU - Cordeiro, M. N.

AU - Moura, R. R.

AU - Moura, R. R.

AU - Coelho, A. V.C.

AU - Nascimento, K. C.G.

AU - Silva Neto, J. C.

AU - Crovella, S.

AU - Crovella, S.

AU - Crovella, S.

AU - Freitas, A. C.

PY - 2017/8/17

Y1 - 2017/8/17

N2 - © 2017 The Authors. Human papillomavirus (HPV) infection is considered a risk factor for cervical cancer. Even if the high-risk HPV (HR-HPV) infection is necessary, environmental co-factors and genetic susceptibility also play an important role in cervical cancer development. In this study, a possible association of rs1695 GSTP1 polymorphisms, HR-HPV infection, and oral contraceptive use with cancer lesion development in women was investigated. The study population comprised 441 Brazilian women from the Northeast region including 98 HPV-infec ted women with high-grade squamous intraepithelial lesions, 77 HPV-infected women with low-grade squamous intraepithelial lesions, and 266 HPV-negative women with no lesion, used as a control. Our data did not show a significant association between the GSTP1 polymorphism A/G (rs1695) and any HPV-related cervical abnormalities. However, considering the use of oral contraceptives, the GSTP1 rs1695 polymorphism was associated with higher susceptibility to the development of cervical lesions in HR-HPV-infected women. Our study suggests a synergic effect of oral contraceptive use, GSTP1 polymorphisms, and HR-HPV infection in the development of cervical lesions. Together, these risk factors may induce neoplastic transformation of the cervical squamous epithelium, setting conditions for secondary genetic events leading to cervical cancer.

AB - © 2017 The Authors. Human papillomavirus (HPV) infection is considered a risk factor for cervical cancer. Even if the high-risk HPV (HR-HPV) infection is necessary, environmental co-factors and genetic susceptibility also play an important role in cervical cancer development. In this study, a possible association of rs1695 GSTP1 polymorphisms, HR-HPV infection, and oral contraceptive use with cancer lesion development in women was investigated. The study population comprised 441 Brazilian women from the Northeast region including 98 HPV-infec ted women with high-grade squamous intraepithelial lesions, 77 HPV-infected women with low-grade squamous intraepithelial lesions, and 266 HPV-negative women with no lesion, used as a control. Our data did not show a significant association between the GSTP1 polymorphism A/G (rs1695) and any HPV-related cervical abnormalities. However, considering the use of oral contraceptives, the GSTP1 rs1695 polymorphism was associated with higher susceptibility to the development of cervical lesions in HR-HPV-infected women. Our study suggests a synergic effect of oral contraceptive use, GSTP1 polymorphisms, and HR-HPV infection in the development of cervical lesions. Together, these risk factors may induce neoplastic transformation of the cervical squamous epithelium, setting conditions for secondary genetic events leading to cervical cancer.

KW - Cervical cancer

KW - Contraceptive

KW - Glutathione S-transferase

KW - Human papillomavirus

UR - http://www.scopus.com/inward/record.url?scp=85028327950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028327950&partnerID=8YFLogxK

U2 - 10.4238/gmr16039742

DO - 10.4238/gmr16039742

M3 - Article

AN - SCOPUS:85028327950

VL - 16

JO - Genetics and Molecular Research

JF - Genetics and Molecular Research

SN - 1676-5680

IS - 3

ER -